Results
|
|
4001.
|
|
|
|
4002.
|
|
|
|
4003.
|
|
|
|
4004.
|
|
|
|
4005.
|
|
|
|
4006.
|
|
|
|
4007.
|
|
|
|
4008.
|
|
|
|
4009.
|
|
|
|
4010.
|
|
|
|
4011.
|
|
|
|
4012.
|
|
|
|
4013.
|
|
|
|
4014.
|
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity. [electronic resource] by
- Elliott, Richard L
- Cameron, Kimberly O
- Chin, Janice E
- Bartlett, Jeremy A
- Beretta, Elena E
- Chen, Yue
- Jardine, Paul Da Silva
- Dubins, Jeffrey S
- Gillaspy, Melissa L
- Hargrove, Diane M
- Kalgutkar, Amit S
- LaFlamme, Janet A
- Lame, Mary E
- Martin, Kelly A
- Maurer, Tristan S
- Nardone, Nancy A
- Oliver, Robert M
- Scott, Dennis O
- Sun, Dexue
- Swick, Andrew G
- Trebino, Catherine E
- Zhang, Yingxin
Producer: 20110329
In:
Bioorganic & medicinal chemistry letters vol. 20
Availability: No items available.
|
|
|
4015.
|
|
|
|
4016.
|
|
|
|
4017.
|
|
|
|
4018.
|
|
|
|
4019.
|
|
|
|
4020.
|
|